Your browser doesn't support javascript.
loading
Outcomes of robot-assisted laparoscopic extended pelvic lymph node dissection for prostate Cancer.
Sigg, Silvan; Lehner, Fabienne; Keller, Etienne Xavier; Saba, Karim; Moch, Holger; Sulser, Tullio; Eberli, Daniel; Mortezavi, Ashkan.
Afiliação
  • Sigg S; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Lehner F; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Keller EX; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Saba K; Urologiezentrum Hirslanden, Hirslanden Klinik Aarau, Aarau, Switzerland.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Sulser T; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Eberli D; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Mortezavi A; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. ashkan.mortezavi@usb.ch.
BMC Urol ; 24(1): 24, 2024 Jan 29.
Article em En | MEDLINE | ID: mdl-38287319
ABSTRACT

INTRODUCTION:

Extended pelvic lymph node dissection (ePLND) in men undergoing robot-assisted laparoscopic radical prostatectomy (RARP) is a widely used procedure. However, little is known about anatomical site-specific yields and subsequent metastatic patterns in these patients. PATIENTS AND

METHODS:

Data on a consecutive series of 1107 patients undergoing RARP at our centre between 2004 and 2018 were analysed. In men undergoing LN dissection, the internal, external and obturator nodes were removed and sent in separately. We performed an analysis of LN yields in total and for each anatomical zone, patterns of LN metastases and complications. Oncological outcome in pN+ disease was assessed including postoperative PSA persistence and survival.

RESULTS:

A total of 823 ePLNDs were performed in the investigated cohort resulting in 98 men being diagnosed as pN+ (8.9%). The median (IQR) LN yield was 19 (14-25), 10 (7-13) on the right and 9 (6-12) on the left side (P < 0.001). A median of six (4-8) LNs were retrieved from the external, three (1-6) from the internal iliac artery, and eight (6-12) from the obturator fossa. More men had metastatic LNs on the right side compared to the left (41 vs. 19). Symptomatic lymphoceles occurred exclusively in the ePLND group (2.3% vs. 0%, p = 0.04). Postoperatively, 47 (47.9%) of men with pN+ reached a PSA of < 0.1µg/ml. There was no association between a certain pN+ region and postoperative PSA persistence or BCRFS. The estimated cancer specific survival rate at 5 years was 98.5% for pN+ disease.

CONCLUSION:

Robot-assisted laparoscopic ePLND with a high LN yield and low complication rate is feasible. However, we observed an imbalance in more removed and positive LNs on the right side compared to the left. A high rate of postoperative PSA persistence and early recurrence in pN+ patients might indicate a possibly limited therapeutical value of the procedure in already spread disease. Yet, these men demonstrated an excellent survival.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Robótica / Laparoscopia Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Robótica / Laparoscopia Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça